Related Experiment Video
Updated: May 15, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Pre-exposure Prophylaxis: Clinical Considerations for Overcoming Barriers to Uptake and Persistence
Nathaniel Albright1,2,3, Adam Leonard1,2,3, Alanna J Bergman1,2,3
1Nathaniel Albright, MSN, RN, FNP-BC, AAHIVS, is a doctoral candidate, Ohio State University College of Nursing, Columbus, Ohio, USA.
Pre-exposure prophylaxis (PrEP) prevents HIV infection. Addressing barriers to PrEP uptake and persistence is crucial for the HIV epidemic strategy, requiring multilevel solutions for priority populations.
Area of Science:
- Public Health
- Infectious Disease Prevention
- HIV/AIDS Research
Background:
- Pre-exposure prophylaxis (PrEP) is a key strategy for preventing HIV infection.
- Current PrEP options include oral and long-acting injectable antiretroviral medications.
- Despite its effectiveness, PrEP uptake and persistence remain suboptimal among those who could benefit.
Purpose of the Study:
- To identify barriers to PrEP care among priority populations.
- To discuss evidence-based solutions for improving PrEP access and adherence.
- To propose multilevel considerations for increasing PrEP utilization.
Main Methods:
- Review of existing literature on PrEP barriers and facilitators.
- Analysis of socio-ecologic factors influencing PrEP uptake and persistence.
- Synthesis of evidence-based interventions and strategies.
Main Results:
- Barriers to PrEP care are complex, spanning individual, interpersonal, community, and structural levels.
- Priority populations face unique challenges in accessing and adhering to PrEP.
- Multilevel interventions are necessary to address these multifaceted barriers.
Conclusions:
- Overcoming barriers to PrEP requires a comprehensive approach involving clinicians, researchers, and communities.
- Implementing evidence-based solutions can enhance PrEP uptake and persistence.
- Increased access to and sustained use of PrEP are vital for ending the HIV epidemic.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Desensitization and Tachyphylaxis
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

